What is the estimated value of this tender?

The estimated value published by the buyer is 1 kr.

Who is the buyer of this tender?

The contracting authority is Region Skåne, Koncernstab inköp och ekonomistyrning (European Union).

Awarded European Union

Läkemedel Kadcyla - substansen trastuzumab emtans

Buyer: Region Skåne, Koncernstab inköp och ekonomistyrning

Open in El Vínculo

Published: 19 January 2024
Estimated value: 1 kr
Procedure: neg-wo-call
Lots: 1
Notice number: 00039250-2024
Reference: 2a4a68bb-c2a2-4fb6-9405-9f0ebbb4beef
Official source: Official source

CPV codes

33600000Productos farmacéuticos

Description

Avtalet omfattar läkemedlet Kadcyla innehållande den aktiva sub-stansen trastuzumab emtansin (L01FD03). --- Ang uppgift för upphandlingens värde I enlighet med svensk lagstiftning görs bedömning att uppgiften om pris/värde ska beläggas med SEKRETESS enligt Offentlighet och sekretesslagen (OSL) 31 kap 16§. Siffran "1" har angetts i fältet "Värde".

Awards

Awarded to	Amount	Date
Roche AB	—	—

Frequently asked questions

What is the estimated value of this tender?: The estimated value published by the buyer is 1 kr.
Who is the buyer of this tender?: The contracting authority is Region Skåne, Koncernstab inköp och ekonomistyrning (European Union).

Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.